OPALEYE MANAGEMENT INC. – Keros Therapeutics, Inc. Transaction History
OPALEYE MANAGEMENT INC. portfolio value:
$12.08M
portfolio value
OPALEYE MANAGEMENT INC. quarter portfolio value change:
+36.16%
quarter
Keros Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +16.41% | 45.3K shares | 4.46M | $37.62 | 321.3K |
| Q2 2022 | share | Increase | +3.86% | 10.25K shares | -6.82M | $27.63 | 276K |
| Q1 2022 | share | 0.00% | 0 shares | -1.09M | $54.38 | 265.75K | |
| Q4 2021 | share | Decrease | -24.61% | -86.75K shares | 1.60M | $56.3 | 265.75K |
| Q3 2021 | share | Increase | +50.00% | 117.5K shares | 3.96M | $39.56 | 352.5K |
| Q2 2021 | share | Increase | +49.21% | 77.5K shares | 286K | $42.47 | 235K |
| Q1 2021 | share | Increase | 0.00% | 157.5K shares | 9.69M | $61.55 | 157.5K |